Wildfire recovery efforts extend far beyond the rebuilding days after the flames are out — sometimes continuing quietly in ...

YUVIWEL was granted orphan drug exclusivity by U.S. FDA to increase linear growth in pediatric patients 2 years of age and older with ...

YUVIWEL was granted orphan drug exclusivity by U.S. FDA to increase linear growth in pediatric patients 2 years of age and older with achondroplasia with open epiphyses - YUVIWEL is now commercially ...

Detailed price information for Ascendis Pharma ADR (ASND-Q) from The Globe and Mail including charting and trades.

Soligenix (NASDAQ: SNGX) reported 2025 results highlighting progress across its rare disease pipeline, including advancing ...

Soligenix (NASDAQ: SNGX) reported 2025 results highlighting progress across its rare disease pipeline, including advancing its Phase 3 FLASH2 trial of HyBryte (TM) for cutaneous T-cell lymphoma with ...

New Drug Application (NDA) for QTORIN™ rapamycin for the treatment of microcystic lymphatic malformations (microcystic LMs) on track for planned ...

Closes Private Placement Financing of Up to $104.5 Million - Secures Orphan Drug Designations for QRX003 for Netherton Syndrome (NS) in the U.S. and Europe - Advances Proposed Expedited Regulatory ...

This post has been updated. Two orphaned black bear cubs are currently being raised in total silence at the Humane Society’s Ramona Wildlife Center. The center is one […] ...

Detailed price information for Quoin Pharmaceuticals Ltd ADR (QNRX-Q) from The Globe and Mail including charting and trades.

BLAINVILLE, QC, April 7, 2026 /PRNewswire/ - Duchesnay, a Canadian specialty pharmaceutical company with a long-standing commitment to women's health, member of Duchesnay Pharmaceutical Group (DPG), ...